skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 3
Patent #:
NONE
Issue Dt:
Application #:
12470814
Filing Dt:
05/22/2009
Publication #:
Pub Dt:
12/31/2009
Inventors:
Matthew Gregory Bursavich, Adam Matthew Gilbert, Joseph Raymond Stock
Title:
Piperazine Metabotropic Glutamate Receptor 5 (MGLUR5) Negative Allosteric Modulators For Anxiety/Depression
Assignment: 1
Reel/Frame:
022825/0359Recorded: 06/15/2009Pages: 8
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
06/01/2009
Exec Dt:
06/04/2009
Exec Dt:
06/01/2009
Assignee:
FIVE GIRALDA FARMS
MADISON, NEW JERSEY 07940
Correspondent:
MICHAEL J. HERMAN
FIVE GIRALDA FARMS
MADISON, NJ 07940
Assignment: 2
Reel/Frame:
023246/0560Recorded: 09/17/2009Pages: 8
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
08/27/2009
Exec Dt:
09/11/2009
Exec Dt:
09/10/2009
Assignee:
FIVE GIRALDA FARMS
MADISON, NEW JERSEY 07940
Correspondent:
MICHAEL J. HERMAN
FIVE GIRALDA FARMS
MADISON, NJ 07940
Assignment: 3
Reel/Frame:
023638/0465Recorded: 12/11/2009Pages: 20
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
11/19/2009
Exec Dt:
11/18/2009
Exec Dt:
11/30/2009
Exec Dt:
11/18/2009
Exec Dt:
11/20/2009
Exec Dt:
11/19/2009
Exec Dt:
11/20/2009
Exec Dt:
11/20/2009
Assignee:
FIVE GIRALDA FARMS
MADISON, NEW JERSEY 07940
Correspondent:
MICHAEL J. HERMAN
FIVE GIRALDA FARMS
MADISON, NJ 07940

Search Results as of: 05/14/2024 10:20 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT